Related Experiment Video
Updated: May 18, 2026

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
Baclofen for the treatment of alcohol dependence
1University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. HowlandRH@upmc.edu
Abstract:
The amino acid gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the nervous system. The mesolimbic dopamine system is a major component of the brain's reward pathways, and GABA neurons are part of this system, decreasing the activity of dopamine neurons through the inhibitory effects of GABA-B receptors. Because the mesolimbic dopamine system has been linked to the reinforcing effects of alcohol and other drugs of abuse, baclofen (Lioresal(®), Gablofen(®)), a GABA-B receptor agonist drug, has been investigated in preclinical studies as a potential treatment for addictions. Baclofen reduces the reinforcing effects of alcohol and other drugs in animals, providing justification for clinical studies in human beings. Two open-label and two placebo-controlled studies in humans found that baclofen was effective for reducing alcohol craving and intake, but one placebo-controlled study found no benefit for baclofen. Baclofen is a safe and well-tolerated novel drug treatment for alcohol dependence.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
CNS Depressants: Barbiturates and Benzodiazepines
Skeletal Muscle Relaxants: Therapeutic Uses
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
